SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-12-266704
Filing Date
2012-06-11
Accepted
2012-06-11 16:04:09
Documents
3
Period of Report
2012-06-06
Filing Date Changed
2012-06-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d365432d8k.htm 8-K 13230
2 PRESS RELEASE, DATED JUNE 6, 2012 d365432dex99.htm EX-99 8769
3 GRAPHIC g365432g09l04.jpg GRAPHIC 28453
  Complete submission text file 0001193125-12-266704.txt   62833
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 12900507
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10